SCHEMBL23761010

SCHEMBL23761010

CNc1nc(N)nc2c1ncn2[C@](C)(O)[C@H](O)C(CO)OC

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA3 P0DMS8 7/20 0.43
ADORA1 P30542 7/20 0.43
ADORA2B P29275 5/20 0.40
CDK1 P06493 2/20 0.37
PRKACA P17612 1/20 0.37
CCNA2 P20248 1/20 0.37
PRKACG P22612 1/20 0.37
PRKACB P22694 1/20 0.37
CDK2 P24941 1/20 0.37
MAPK3 P27361 1/20 0.37
MAPK1 P28482 1/20 0.37
CCNA1 P78396 1/20 0.37
ADORA2A P29274 1/20 0.34
CDC20 Q12834 1/20 0.32
PGK1 P00558 1/20 0.32
PGK2 P07205 1/20 0.32
YTHDC1 Q96MU7 1/20 0.32
HDAC1 Q13547 2/20 0.32
HDAC2 Q92769 2/20 0.32
HDAC8 Q9BY41 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22889219 0.89 ADORA3 (0.42) ADORA3ADORA1ADORA2BCDK1PRKACA
SCHEMBL24082139 0.87 NR1I2 (0.46) ADORA3ADORA1ADORA2BCDK1PRKACA
SCHEMBL18831799 0.85 HSP90AB1 (0.40)
SCHEMBL23761068 0.79 CCNE2 (0.39) CDK1CDK2
SCHEMBL22580302 0.77 ADORA3 (0.39) ADORA3ADORA1ADORA2BCDK1PRKACA
SCHEMBL20052484 0.77 PI4KA (0.52) ADORA1ADORA2BADORA2A
SCHEMBL22224567 0.76 CDK2 (0.44) ADORA3ADORA1ADORA2BCDK1PRKACA
SCHEMBL22580897 0.75 CDK1 (0.43) ADORA2BCDK1CDK2ADORA2A
SCHEMBL26039600 0.74 ADORA3 (0.36) ADORA3ADORA1ADORA2BCDK1PRKACA
SCHEMBL19644788 0.72 PDE4A (0.32) CDK1CDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3865136-A1 2'-SUBSTITUTED-N6-SUBSTITUTED PURINE NUCLEOTIDES FOR CORONA VIRUS TREATMENT ATEA Pharmaceuticals, Inc. (US) 2021-08-18 EP disclosed